New Delhi: The Union Budget 2026–27 has set the stage for India to emerge as a global biopharmaceutical hub with the launch of Biopharma SHAKTI, a ₹10,000 crore initiative over five years. The program aims to strengthen the country’s capabilities in biologics and biosimilars, reduce import dependence, and capture 5%…
